Psychopathy: clinical features, developmental basis and therapeutic challenges.

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Psychopathy is a personality disorder marked by interpersonal, affective, lifestyle, and behavioral deficits.
• Clinical features include pathological lying, lack of remorse, impulsivity, and poor behavioral controls.

Purpose of the Study:

• Provide clinicians with an understanding of psychopathy's clinical features.
• Explain the structural, functional, genetic, and environmental underpinnings of psychopathy.
• Summarize current pharmacological treatment approaches for psychopathy.

Main Methods:

• Comprehensive literature search of MEDLINE/PubMed, Web of Science, and International Pharmaceutical Abstracts.
• Inclusion of human and animal drug therapy articles, prioritizing controlled trials.
• Searched bibliographies and Amazon books for relevant information on psychopathy and sociopathy.

Main Results:

• Psychopathy affects 0.6-4% of the general population, with a higher prevalence in males.
• Brain imaging reveals reduced amygdala and prefrontal cortex activity in psychopaths.
• Physiological abnormalities include neurotransmitter, endocrine, and autonomic system dysregulation.

Conclusions:

• Psychopathy has significant negative impacts on individuals and society.
• Further research is crucial to understand the pathophysiology and developmental factors of psychopathy.
• Emerging evidence suggests phenotypic variants, highlighting the need for clinical awareness.